Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial

This publication has 18 references indexed in Scilit:

• Gemcitabine/carboplatin in advanced non-small cell lung cancer
  Lung Cancer, 2002
• Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer
  New England Journal of Medicine, 2002
• Relationship between quality of life and clinical outcomes in advanced non-small cell lung cancer: best supportive care (BSC) versus BSC plus chemotherapy
  Lung Cancer, 1999
• Quality of Life in Patients With Lung Cancer
  Chest, 1998
• 45 Survival advantage for carboplatin 500 mg/mg2 substituting cisplatin 120 mg/m2 in combination with vindesine and mitomycin C in patients with stage IIIB and IV squamous-cell bronchogenic carcinoma: A randomized phase III study in 221 patients
  Lung Cancer, 1997
• Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials
  BMJ, 1995
• The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials
  European Journal Of Cancer, 1994
• The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
  JNCI Journal of the National Cancer Institute, 1993
• Analysis of clinical trials by treatment actually received: Is it really an option?
  Statistics in Medicine, 1991
• Measuring the quality of life of cancer patients
  Journal of Chronic Diseases, 1981